Nucleic Acid Lateral Flow Immunoassay (NALFIA)
NALFIA (Nucleic Acid Lateral Flow Immunoassay) is a general device that combines lateral flow technology and immunoassay principle for detection of nucleic acid related products, such as PCR products, genetic amplicons. NALFIA was first developed for immunoassay as the point-of-care (POC) tests in molecular diagnosis in 2006 and attracted a lot of interest from researchers and developers in the public and private sectors. Under some conditions where the molecular biology laboratory infrastructure is basic or almost absent, NALFIA as a simple and easy-to-use POC product, is particularly demanded. Until today, an increasing number of nucleic acid later flow test has been applied in the domain of infectious disease (human, animal, and plant), food safety analysis, genotyping and environmental contamination monitoring.